MedTech News
.................... by Andrew Celentano
Onkos Surgical® Receives FDA 510(k) Clearance for Application of NanoCept® Antibacterial Technology to Titanium Implants in the ELEOS™ Limb Salvage System
PARSIPPANY, N.J., June 9, 2026 /PRNewswire/ — Onkos Surgical, a leader in innovative solutions for musculoskeletal oncology and complex orthopaedic conditions, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for the application of its NanoCept Antibacterial Technology on titanium implants within the ELEOS Limb Salvage System.
Rare, Possibly More Severe Lyme Bacterium Found in New York Ticks for the First Time
A case in Herkimer County, New York, led health officials to uncover local tick transmission of Borrelia mayonii, a rare Lyme disease bacterium once known only from the Midwest.
FDA clears Xenix Medical’s Lux fusion system
Designed for spinal fusion surgery, Lux is designed to increase the chances of procedural success and provide greater flexibility once implants are fitted.
Gore wins CE mark for Fortegra venous stent
W.L. Gore & Associates announced today that it received CE mark approval for its Viabahn Fortegra venous stent system.
EBR systems earns Medicare win for leadless pacing tech
EBR Systems said today that a new Medicare National Coverage Determination (NCD) will evaluate its leadless endocardial pacing technology.
AI can reveal brain tumor risks without costly genetic testing
Mayo Clinic researchers and collaborators have shown that artificial intelligence (AI) can analyze routine pathology slides to help classify meningiomas, the most common primary brain tumor in adults, and predict a patient’s risk of tumor recurrence.
Researchers trigger sleep’s restorative effect in parts of the awake brain
By inducing specific patterns of activity in small portions of the brain in awake mice, researchers have triggered a recalibration of neural connections that normally only occurs during sleep. This new approach offset the effects of sleep deprivation on memory tasks and revealed features of sleep that are key to its restorative effect.
Ultrasound turns anticancer molecule into deep-lung bacteria killer
An anticancer medication called TLD1433, a ruthenium(II) complex that has entered Phase II trials for conditions such as non-muscle-invasive bladder cancer, is now being repurposed to address one of the biggest public health issues globally—bacterial infections.